Advancing the Pharmaceutical Development of Orphan Drugs for Rare Diseases
We are dedicated to accelerating the development of new drugs for patients around the world. We provide CRO and CDMO services including formulation development, clinical pharmacology trials, and clinical and commercial manufacturing services to the pharmaceutical and biotech industry. These services are provided either individually or as an integrated service offering via our Translational Pharmaceutics® platform.
Quotient is your answer.
Quotient is your answer.
Quotient is your answer.
Quotient is your answer.
Quotient is your answer.
Our latest updates
News
Quotient and ANA Therapeutics announce partnership to develop drug candidate, ANA001 (niclosamide capsules) as a potential treatment for COVID-19.
Event
Discuss your drug development requirements with us at the 10th American Drug Delivery and Formulation event in San Diego from 14-15 December 2020
Webinar
This webinar discusses effective strategies being used by biotech and pharmaceutical companies to overcome biopharmaceutic challenges for small molecules in today’s drug development pipeline; and explores alternative approaches for accelerating your early development plan.
Awards
Quotient Sciences, a global drug development and manufacturing organization has been recognized as a “Top Pharma and Life Sciences Outsourcing Services Company in the UK for 2020” by PharmaTech Outlook magazine.
Ask us a question
